Gene · 9170
Papers3,539
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,539
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Biased agonism at free-fatty acid receptor-4 (FFA4/GPR120). | Pharmacol Ther | 2025 | 39719174 | PubTator, text mining | PubMed |
| The role of lysophosphatidic acid and its receptors in corneal nerve regeneration. | Ocul Surf | 2025 | 39709127 | PubTator, text mining | PubMed |
| Cellular responses to low nutrient conditions via activation of lysophosphatidic acid (LPA) receptor signaling in gastric cancer cells. | Adv Biol Regul | 2025 | 39626328 | PubTator, text mining | PubMed |
| Molecular mechanisms underlying glucose-dependent insulinotropic polypeptide secretion in human duodenal organoids. | Diabetologia | 2025 | 39441374 | PubTator, text mining | PubMed |
| Identification of pivotal genes and crucial pathways in liver fibrosis through WGCNA analysis. | Technol Health Care | 2025 | 39177628 | PubTator, text mining | PubMed |
| GRPR Drives Metastasis via CRABP2 and FNDC4 Pathways in Lung Adenocarcinoma. | Cells | 2024 | 39768218 | PubTator, text mining | PubMed |
| Inhibition of lysophosphatidic acid receptor 2 attenuates neonatal chronic lung disease in mice by preserving vascular and alveolar development. | Eur J Pharmacol | 2024 | 39522686 | PubTator, text mining | PubMed |
| Immunometabolism: signaling pathways, homeostasis, and therapeutic targets. | MedComm (2020) | 2024 | 39492834 | PubTator, text mining | PubMed |
| Force versus Response: Methods for Activating and Characterizing Mechanosensitive Ion Channels and GPCRs. | Adv Healthc Mater | 2024 | 39402780 | PubTator, text mining | PubMed |
| Leukotriene B4 receptor 1 (BLT1) activation by leukotriene B4 (LTB4) and E resolvins (RvE1 and RvE2). | Comput Biol Chem | 2024 | 39395248 | PubTator, text mining | PubMed |
| Targeting the Adenosine A2A Receptor as a Novel Therapeutic Approach for Renal Cell Carcinoma: Mechanisms and Clinical Trial Review. | Pharmaceutics | 2024 | 39339165 | PubTator, text mining | PubMed |
| The Effect of Ionizing Irradiation on the Autotaxin-Lysophasphatidic Acid Axis and Interleukin-6/8 Secretion in Different Breast Cancer Cell Lines. | J Pers Med | 2024 | 39338222 | PubTator, text mining | PubMed |
| Insights into autotaxin- and lysophosphatidate-mediated signaling in the pancreatic ductal adenocarcinoma tumor microenvironment: a survey of pathway gene expression. | Am J Cancer Res | 2024 | 39267662 | PubTator, text mining | PubMed |
| The role of LPA receptor signaling in modulating cellular responses of colon cancer cells co-cultured with lymphoid endothelial cells under hypoxic stress. | Tissue Cell | 2024 | 39208538 | PubTator, text mining | PubMed |
| Unveiling potential drug targets for lung squamous cell carcinoma through the integration of druggable genome and genome-wide association data. | Front Genet | 2024 | 39175755 | PubTator, text mining | PubMed |
| LPA3 agonist-producing Bacillus velezensis ADS024 is efficacious in multiple neuroinflammatory disease models. | Brain Behav Immun | 2024 | 39147172 | PubTator, text mining | PubMed |
| Lysophosphatidic Acid Receptors LPAR5 and LPAR2 Inversely Control Hydroxychloroquine-Evoked Itch and Scratching in Mice. | Int J Mol Sci | 2024 | 39125747 | PubTator, text mining | PubMed |
| Withdrawal: Lysophosphatidic acid stimulates the G-protein-coupled receptor EDG-1 as a low affinity agonist. | J Biol Chem | 2024 | 39096771 | PubTator, text mining | PubMed |
| Erratum for the Report "Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1" by M.-J. Lee et al. | Science | 2024 | 39088640 | PubTator, text mining | PubMed |
| Application and Method of Surface Plasmon Resonance Technology in the Preparation and Characterization of Biomedical Nanoparticle Materials. | Int J Nanomedicine | 2024 | 39011388 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9170/papers?page=6